Italy: clinical trials of Novartis 2017, by therapeutic area
This statistic depicts the distribution of clinical trials of the pharmaceutical company Novartis in Italy in 2017, by therapeutic area. According to data, 55.5 percent of studies funded by Novartis were conducted in in the field of oncology, the most investigated therapeutic area. Clinical trials regarding immunology and dermatology held 17.7 percent of share, followed by cardiometabolic studies with 9.1 percent.